Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle

scientific article published on 04 July 2013

Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1007077236
P356DOI10.1186/1297-9716-44-48
P932PMC publication ID3720265
P698PubMed publication ID23826638
P5875ResearchGate publication ID245536610

P50authorHui-Chen GuoQ120571234
Shi-Qi SunQ120571445
P2093author name stringHong Yin
Ye Jin
Jian-Xun Luo
Xiang-Tao Liu
Jian-Hong Guo
Jun-Wu Ma
Ding Xiang Liu
Zai-Xin Liu
De-Hui Sun
Yan-Quan Wei
Shuang-Hui Yin
Shun-Li Yang
P2860cites workUse of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genesQ27860623
Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolutionQ28756233
SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins.Q30342324
Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccineQ33338439
New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccinesQ33573531
Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coliQ33636884
Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.Q33822639
Structures of virus and virus-like particlesQ33885190
Development of a foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupaeQ34405725
Foot-and-mouth diseaseQ34547126
Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001.Q35043566
Control and eradication of foot-and-mouth diseaseQ35044863
Protective immune response against foot-and-mouth diseaseQ35226002
Foot-and-mouth disease: host range and pathogenesisQ36008121
An efficient system for high-level expression and easy purification of authentic recombinant proteinsQ36526542
Virus-like particles: passport to immune recognitionQ36602264
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosomeQ36686327
The coming of age of virus-like particle vaccinesQ37309265
Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli.Q37329062
Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding proteinQ38328649
FMD subunit vaccine produced using a silkworm–baculovirus expression system: Protective efficacy against two type Asia1 isolates in cattleQ39627361
Formation of virus-like particles from O-type foot-and-mouth disease virus in insect cells using codon-optimized synthetic genesQ39704435
Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheepQ39740005
Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.Q39869070
Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity.Q39879004
Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigsQ39891157
Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virusQ40015542
Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.Q40165012
Stability and immunogenicity of empty particles of foot-and-mouth disease virusQ40214915
Relationship Between Virus Neutralization and Serum Protection Bioassays for IgG and IgM Antibodies to Foot-and-Mouth Disease VirusQ40218387
Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.Q40422822
Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.Q40433851
Evaluation of automated RT-PCR to accelerate the laboratory diagnosis of foot-and-mouth disease virus.Q40680381
Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variantsQ41060791
Affinity fusion strategies for detection, purification, and immobilization of recombinant proteinsQ41608082
Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L proteaseQ41899098
Co-overexpression of folding modulators improves the solubility of the recombinant guinea pig liver transglutaminase expressed in Escherichia coliQ44032781
Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagentsQ44659482
The solubility and stability of recombinant proteins are increased by their fusion to NusA.Q45035964
Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potencyQ45354442
Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C proteaseQ45387024
Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China.Q45398156
The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virusQ45564180
The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cellsQ45730227
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.Q45733658
Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression systemQ45767549
A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. ApplicationQ45835912
A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA.Q45835914
Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processingQ45845067
Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sitesQ45847241
High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system.Q54561263
Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan.Q55034194
Rapid protein-folding assay using green fluorescent proteinQ56902199
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antiviralsQ57103184
Clinical and laboratory investigations of five outbreaks of foot-and-mouth disease during the 2001 epidemic in the United KingdomQ57105118
In vitro assembly of poliovirus 14 S subunits: Identification of the assembly promoting activity of infected cell extractsQ67912405
The relationship between serum antibody titres and protection from foot and mouth disease in pigs after oil emulsion vaccinationQ72411315
P921main subjectEscherichia coliQ25419
foot-and-mouth disease virusQ1911079
foot-and-mouth diseaseQ152401
P304page(s)48
P577publication date2013-07-04
P1433published inVeterinary ResearchQ15761008
P1476titleFoot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle
P478volume44

Reverse relations

cites work (P2860)
Q42197160A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.
Q41071634A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles
Q38252451Adjuvants for foot-and-mouth disease virus vaccines: recent progress
Q28537703Binding of glutathione to enterovirus capsids is essential for virion morphogenesis
Q57008195Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity
Q28080092Challenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in Pigs
Q42002998Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system.
Q39063658Foot-and-mouth disease vaccines
Q38694452Foot-and-mouth disease vaccines: progress and problems
Q38208419Foot-and-mouth disease: technical and political challenges to eradication.
Q38851217Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines
Q59351586Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine
Q102142384Green preparation of hydrogel particles-in-emulsions for simultaneous enhancement of humoral and cell-mediated immunity
Q40156866Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Q36066573Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.
Q45323916Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Q35941324Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves
Q42233344Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine
Q56556960Single-domain antibodies as promising experimental tools in imaging and isolation of porcine epidemic diarrhea virus
Q33812653Subviral particle as vaccine and vaccine platform
Q38603912The application of virus-like particles as vaccines and biological vehicles
Q38265915Three-dimensional structure of foot-and-mouth disease virus and its biological functions
Q38197494Virus-like particles in picornavirus vaccine development

Search more.